Archives
-
From GABRA1 Proteostasis to Surface Biology
2026-09-05
GABRA1 frameshift variants expose a central translational challenge: total receptor abundance does not necessarily reveal how much functional protein reaches the cell surface. This thought-leadership article explains how Sulfo-NHS-SS-Biotin can help separate surface delivery from intracellular retention, while outlining experimental controls, competitive advantages, and the limits of extending a biochemical labeling strategy into disease-mechanism research.
-
Fluo-4 AM Calcium Assay Kit for Mechanotransduction
2026-09-04
Use the Fluo-4 AM Calcium Assay Kit to convert scaffold-driven Ca2+ signaling into a practical readout for annulus fibrosus cell phenotyping. Its 488 nm excitation, staining enhancers, and no-wash format support both mechanobiology workflows and scalable GPCR screening.
-
Magneto-Piezoelectric Scaffolds for Infected Bone Repair
2026-09-04
This ACS Nano study develops a dual-responsive, 3D-printed scaffold that combines magnetic biofilm disruption with ultrasound-triggered metabolic activation of Icam1+ macrophages. The work links JAK2-STAT3-associated oxidative phosphorylation to pro-reparative immune signaling, offering a coordinated strategy for infection control and bone regeneration.
-
Serotonin Inhibition of HRP Protein Labelling
2026-09-03
Chan and colleagues identify serotonin as a previously unrecognized inhibitor of HRP-mediated proximity biotinylation, while dopamine produces little interference under the tested conditions. Their combination of cell-based assays and label-free quantitative proteomics shows that Dz-PEG can consume serotonin and restore labelling efficiency, providing an important control strategy for serotonergic neuroscience workflows.
-
Quaternization Converts Spleen to Lung mRNA Tropism
2026-09-03
Huang and colleagues show that N-quaternization of the lipid-like compound tB-UC18 converts DOPE nanoassemblies from spleen-biased to highly lung-selective mRNA delivery after intravenous administration. The study identifies a comparatively simple head-group engineering strategy for non-liver delivery, while also highlighting the need to validate organ distribution, cellular uptake, and expression independently in relevant models.
-
Amikacin disulfate: Reliable Assay Workflows
2026-09-02
This scenario-based guide explains how Amikacin disulfate (SKU B1658) can support controlled antibiotic mechanism, protein-interaction, and contamination-related assay workflows without being mistaken for a mammalian viability reagent. It covers solution handling, data interpretation, controls, and practical vendor-selection criteria for reproducible laboratory studies.
-
DiscoveryProbe Natural Product Library Plus for AdhE
2026-09-02
Discover how the DiscoveryProbe Natural Product Library Plus can extend CpAdhE-centered antiparasitic research beyond single-chemotype screening. This mechanism-aware workflow combines biochemical inhibition, cellular phenotyping, and rigorous artifact control for natural product screening for drug discovery.
-
BQCA and the Next Logic of M1 Translation
2026-09-01
A mechanistic and translational perspective on how Benzyl Quinolone Carboxylic Acid (BQCA) can help researchers study M1 receptor signaling, pathway bias, neuronal activity, and Alzheimer’s disease biology with greater experimental precision.
-
Arrb2–6-ketoLCA Axis in Liver IRI
2026-09-01
This 2026 study identifies hepatocyte Arrb2 as a regulator of hepatic ischemia–reperfusion injury, linking hepatocyte signaling to increased 6-ketoLCA and M2 macrophage polarization. Its combination of clinical samples, conditional mouse modeling, hypoxia–reoxygenation experiments, and metabolite profiling provides a mechanistic framework for studying hepatocyte–macrophage communication in transplantation-related liver injury.
-
GS967 Cardiac Late Sodium Current Workflows
2026-08-31
GS967 is a practical cardiac late sodium current inhibitor for connecting abnormal Na⁺ influx with repolarization, calcium handling, relaxation, and arrhythmia phenotypes. This workflow guide shows how to move from ventricular myocyte recordings to aging-heart and ischemia-induced arrhythmia studies while preserving interpretable controls.
-
LC–MS/MS Maps GS-441524 Prodrug Conversion
2026-08-31
A January 2026 Microchemical Journal study used LC–MS/MS to trace how the novel GS-441524 prodrug NGP-1 is converted to GS441, the GS-441524-related active metabolite, across gastric, blood, hepatic, and in vivo systems. The results support a multi-compartment conversion model in which both parent prodrug and released metabolite contribute to exposure after oral administration.
-
CpAdhE Inhibition by Antifungal Imidazoles
2026-08-30
The reference study establishes the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically vulnerable metabolic target in Cryptosporidium parvum. A tiered screen connected enzyme inhibition by antifungal imidazoles with lower-micromolar suppression of parasite growth in vitro, while also defining important limits for therapeutic interpretation.
-
Glioma Organoids Retaining the Tumor Microenvironment
2026-08-29
The reference study introduces glioma organoids with a preserved microenvironment, including resident immune cells, while retaining molecular features of the originating tumor. Its paired genomic, epigenetic, transcriptomic, immunofluorescence, and flow-cytometric analyses support GlioME as a more biologically representative platform for personalized drug screening than simplified floating organoids.
-
SCH772984 HCl: ERK1/2 Inhibitor Workflow
2026-08-28
Build a direct ERK1/2 inhibition workflow for MAPK reactivation, BRAF- and RAS-mutant models, and TERT-centered chromatin studies. This guide pairs dose-response design with orthogonal phospho-signaling, proliferation, transcriptional, and chromatin readouts.
-
Ginsenoside Rg1: Neuroimmune Research Workflow
2026-08-28
Build a translational neuroprotection workflow around Ginsenoside Rg1, connecting behavior, synaptic physiology, cytokines, gut permeability, and regulatory T cells. This practical guide adapts the reference anesthesia model while emphasizing solvent control, assay timing, compound stability, and mechanistic validation.